These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25831793)

  • 1. [Renal dysfunction].
    Fukui T; Yoshioka T
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():411-6. PubMed ID: 25831793
    [No Abstract]   [Full Text] [Related]  

  • 2. Renal effects of novel anticancer targeted therapies: a review of the Food and Drug Administration Adverse Event Reporting System.
    Jhaveri KD; Sakhiya V; Wanchoo R; Ross D; Fishbane S
    Kidney Int; 2016 Sep; 90(3):706-7. PubMed ID: 27521117
    [No Abstract]   [Full Text] [Related]  

  • 3. Onconephrology: What Should the Internist Know About Targeted Therapy in Solid Tumors?
    El Rassy E; El Karak F; Rizkallah J; Chelala D
    Iran J Kidney Dis; 2016 Jul; 10(4):169-75. PubMed ID: 27514761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How to keep kidneys safe while shrinking tumors: the conundrum of cisplatin action.
    Goligorsky MS
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F50-1. PubMed ID: 17507601
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypertension].
    Imai H
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():403-6. PubMed ID: 25831791
    [No Abstract]   [Full Text] [Related]  

  • 6. Side effects of targeted therapies. Introduction.
    Eaby-Sandy B
    Semin Oncol Nurs; 2014 Aug; 30(3):137-8. PubMed ID: 25085024
    [No Abstract]   [Full Text] [Related]  

  • 7. [Are targeted therapies better tolerated?].
    Stiefelhagen P
    MMW Fortschr Med; 2015 Apr; 157(7):23-4. PubMed ID: 26012443
    [No Abstract]   [Full Text] [Related]  

  • 8. [New drugs in oncology: benefits, risks and challenges].
    Cella D; Vervölgyi V; Wörmann B
    Onkologie; 2013; 36 Suppl 5():12-9. PubMed ID: 23921801
    [No Abstract]   [Full Text] [Related]  

  • 9. Is tumor response important for renal carcinoma?
    Inman BA; George DJ
    Eur Urol; 2011 Jan; 59(1):16-7. PubMed ID: 20970245
    [No Abstract]   [Full Text] [Related]  

  • 10. Renal toxicities of chemotherapy.
    de Jonge MJ; Verweij J
    Semin Oncol; 2006 Feb; 33(1):68-73. PubMed ID: 16473645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Managing cutaneous toxicities of targeted therapies].
    Kiyohara Y
    Gan To Kagaku Ryoho; 2012 Nov; 39(11):1597-602. PubMed ID: 23152009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of monitoring renal function in patients with cancer.
    Aapro M; Launay-Vacher V
    Cancer Treat Rev; 2012 May; 38(3):235-40. PubMed ID: 21605937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management and interpretation of novel toxicities of molecular targeted therapies: renal toxicities.
    Carles J; Morales R; Perez JM; Suárez C; Rodón J; Valverde C
    Eur J Cancer; 2009 Sep; 45 Suppl 1():309-17. PubMed ID: 19775627
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of chemotherapy on the kidney.
    Cobos E; Hall RR
    Semin Nephrol; 1993 May; 13(3):297-305. PubMed ID: 8321929
    [No Abstract]   [Full Text] [Related]  

  • 15. Skin care for cancer patients.
    Lacouture ME
    Clin Adv Hematol Oncol; 2012 Nov; 10(11):748-50. PubMed ID: 23271263
    [No Abstract]   [Full Text] [Related]  

  • 16. [Skin disorders].
    Uhara H
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():450-3. PubMed ID: 25831801
    [No Abstract]   [Full Text] [Related]  

  • 17. [Determination of individual kidney function?].
    Lipp HP
    Med Monatsschr Pharm; 2008 Oct; 31(10):393-5. PubMed ID: 18975414
    [No Abstract]   [Full Text] [Related]  

  • 18. Renal complications of cancer therapies.
    Schanz M; Schricker S; Pfister F; Alscher MD; Kimmel M
    Drugs Today (Barc); 2018 Sep; 54(9):561-575. PubMed ID: 30303496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Nephrotoxicity induced by chemotherapy].
    Di Vito R; Sirolli V; Amoroso L; Bonomini M
    G Ital Nefrol; 2011; 28(3):296-304. PubMed ID: 21626498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Management of adverse effects of targeted therapy toxicities in oncology].
    Coquan E; Henri P; de Raucourt S; Lireux B; Lamy E; Delcambre C; Sevin E; Dutriaux C; Bouhier-Leporrier K; Gervais R; Joly F
    Rev Prat; 2012 Jan; 62(1):17-25. PubMed ID: 22335060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.